Ohio Takes a Swing at CBD in Medical Cannabis Market Written by Orion Inskip, Attorney at Gleam Law that specializes in CBD. Yet another state takes a hardline stance against CBD sold outside the regulated medical cannabis market. With the Ohio Pharmacy Board’s recent “Clarification on Cannabidiol (CBD) Oil”, Ohio has joined states like California…

Can Marijuana Legalization Improve Police Clearance Rates? Written by Neil Juneja, Founder & Managing Partner of Gleam Law, PLLC.  The rippling effects of legalizing and regulating marijuana can be difficult to measure. Proponents of legalization are quick to point how many marijuana related arrests are for possession of relatively small amounts and tend to disproportionately…

BREAKING: FDA Approves CBD-Based Medicine Derived from Marijuana Written by Orion Inskip, Attorney at Gleam Law, PLLC.  The Food and Drug Administration (FDA) has approved Epidiolex, an epilepsy medicine derived from marijuana. The drug’s active ingredient is a non-psychoactive cannabinoid known as cannabidiol (CBD) and is the first marijuana-based medication approved by the FDA. This…

Washington State Liquor and Cannabis Board To Increase Number of Enforcement Officers To Meet Growing Backlog of Marijuana-Related Complaints Written by Neil Juneja, Founder & Managing Partner of Gleam Law, PLLC. Justin Nordhorn, Chief of Enforcement for the Washington State Liquor and Cannabis Board (WSLCB), announced that the agency will be increasing the size of…

Using & Enforcing Your New Trademark Written by Neil Juneja, Founder & Managing Partner of Gleam Law, PLLC.  So you have successfully registered a state or federal trademark for your cannabis business or product? Congratulations! Here are the tips we provide to every one of our trademark clients to help them use and enforce their Intellectual…

Understanding trademarks is key to avoid rebranding The announcement of a settlement between the Gorilla Glue Co. and GG Strains is creating a stir on the trademark side of cannabis law.

Marijuana Reform Garnering Cautious Bipartisan Congressional Support Written by Ammon J. Ford, Attorney at Gleam Law, PLLC.  National cannabis policy is more about politics than science and has been for decades. That is as true today as when Richard Nixon pushed the Controlled Substances Act of 1970 to punish anti-war liberals and black civil rights…

White House Signals Change in Marijuana Policy Written by Ammon J. Ford, Attorney at Gleam Law, PLLC.  Under federal law, marijuana of any sort is still highly illegal. As a Schedule 1 controlled substance, it is legally considered equal to heroin and LSD. The Obama Administration’s Department of Justice (DOJ) took a ‘hands off’ approach…

Today, Senator Jefferson Beauregard “Jeff” Sessions III (R-AL) accepted President-Elect Trump’s nomination to become the next Attorney General of the United States, the nation’s top law enforcement official. He’s unapologetically anti-cannabis, and was quoted as saying “Good People Don’t Smoke Marijuana” will that translate into official policy? Sessions’ impressive resume includes six years as Assistant US…

Cannabis is the new hot topic of conversation, moving from the smoky dorm to the board room. The green rush is on, and, and as any gold rush of the past, there is good business in selling the picks and shovels to those seeking their fortunes. Coupled with the most difficult legal market for aspiring…